Nayanta Sodha

2.7k total citations
21 papers, 1.1k citations indexed

About

Nayanta Sodha is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Nayanta Sodha has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Genetics. Recurrent topics in Nayanta Sodha's work include BRCA gene mutations in cancer (9 papers), Cancer-related Molecular Pathways (9 papers) and DNA Repair Mechanisms (4 papers). Nayanta Sodha is often cited by papers focused on BRCA gene mutations in cancer (9 papers), Cancer-related Molecular Pathways (9 papers) and DNA Repair Mechanisms (4 papers). Nayanta Sodha collaborates with scholars based in United Kingdom, United States and France. Nayanta Sodha's co-authors include Rosalind A. Eeles, Michelle D. Garrett, Ian Collins, Laurent Antoni, Hiroko Ohgaki, David E. Goldgar, Paul Kleihues, Magali Olivier, Pierre Hainaut and Richard S. Houlston and has published in prestigious journals such as Science, Nature reviews. Cancer and Cancer Research.

In The Last Decade

Nayanta Sodha

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nayanta Sodha United Kingdom 13 692 521 341 257 175 21 1.1k
Frank Courjal France 11 634 0.9× 403 0.8× 276 0.8× 311 1.2× 127 0.7× 16 1.0k
Tord Jonson Sweden 16 748 1.1× 327 0.6× 261 0.8× 300 1.2× 123 0.7× 28 1.2k
Diana Iliev United States 5 901 1.3× 660 1.3× 274 0.8× 279 1.1× 189 1.1× 8 1.2k
Jonathan Perk United States 7 782 1.1× 272 0.5× 245 0.7× 193 0.8× 83 0.5× 7 994
Michel Herranz Spain 14 1.0k 1.5× 223 0.4× 157 0.5× 322 1.3× 111 0.6× 16 1.2k
Mary K. Washington United States 6 595 0.9× 480 0.9× 214 0.6× 179 0.7× 114 0.7× 10 996
Huai-Xiang Hao United States 10 1.0k 1.5× 471 0.9× 155 0.5× 197 0.8× 152 0.9× 12 1.4k
Sara Volorio Italy 13 900 1.3× 272 0.5× 95 0.3× 191 0.7× 108 0.6× 26 1.1k
Lalitha Nagarajan United States 20 690 1.0× 177 0.3× 175 0.5× 109 0.4× 143 0.8× 46 1.0k
Sean Young Canada 13 261 0.4× 285 0.5× 201 0.6× 143 0.6× 155 0.9× 27 736

Countries citing papers authored by Nayanta Sodha

Since Specialization
Citations

This map shows the geographic impact of Nayanta Sodha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nayanta Sodha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nayanta Sodha more than expected).

Fields of papers citing papers by Nayanta Sodha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nayanta Sodha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nayanta Sodha. The network helps show where Nayanta Sodha may publish in the future.

Co-authorship network of co-authors of Nayanta Sodha

This figure shows the co-authorship network connecting the top 25 collaborators of Nayanta Sodha. A scholar is included among the top collaborators of Nayanta Sodha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nayanta Sodha. Nayanta Sodha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mitra, Anita, Charles Jameson, Yolanda Barbáchano, et al.. (2009). Overexpression of RAD51 occurs in aggressive prostatic cancer. Histopathology. 55(6). 696–704. 81 indexed citations
3.
Evans, D. Gareth, Linda Pointon, Susan J. Ramus, et al.. (2009). Eligibility for Magnetic Resonance Imaging Screening in the United Kingdom: Effect of Strict Selection Criteria and Anonymous DNA Testing on Breast Cancer Incidence in the MARIBS Study. Cancer Epidemiology Biomarkers & Prevention. 18(7). 2123–2131. 10 indexed citations
4.
Titelbaum, David S., Nayanta Sodha, & Majaz Moonis. (2009). Transient Hemiglossal Denervation during Acute Internal Capsule Infarct in the Setting of Dysarthria−Clumsy Hand Syndrome. American Journal of Neuroradiology. 31(7). 1266–1267. 3 indexed citations
5.
Antoni, Laurent, Nayanta Sodha, Ian Collins, & Michelle D. Garrett. (2007). CHK2 kinase: cancer susceptibility and cancer therapy – two sides of the same coin?. Nature reviews. Cancer. 7(12). 925–936. 225 indexed citations
6.
Senzer, Neil, John Nemunaitis, Michael Nemunaitis, et al.. (2007). p53 therapy in a patient with Li-Fraumeni syndrome. Molecular Cancer Therapeutics. 6(5). 1478–1482. 42 indexed citations
7.
Amikam, Dorit, Nayanta Sodha, Lina Basel‐Vanagaite, et al.. (2007). Rapid Development of Post-radiotherapy Sarcoma and Breast Cancer in a Patient with a Novel Germline ‘De-Novo’ TP53 Mutation. Clinical Oncology. 19(7). 490–493. 49 indexed citations
8.
Kote‐Jarai, Zsofia, Trevor J. Powles, Gillian Mitchell, et al.. (2006). BRCA1/BRCA2 mutation status and analysis of cancer family history in participants of the Royal Marsden Hospital tamoxifen chemoprevention trial. Cancer Letters. 247(2). 259–265. 10 indexed citations
9.
Natrajan, Rachael, Nayanta Sodha, JS Reis‐Filho, et al.. (2006). Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour. The Journal of Pathology. 211(1). 52–59. 47 indexed citations
10.
Thompson, Deborah J., Sheila Seal, Mieke Schutte, et al.. (2006). A Multicenter Study of Cancer Incidence in CHEK2 1100delC Mutation Carriers. Cancer Epidemiology Biomarkers & Prevention. 15(12). 2542–2545. 41 indexed citations
11.
Sodha, Nayanta, Tine S. Mantoni, Sean V. Tavtigian, Rosalind A. Eeles, & Michelle D. Garrett. (2006). Rare Germ Line CHEK2 Variants Identified in Breast Cancer Families Encode Proteins That Show Impaired Activation. Cancer Research. 66(18). 8966–8970. 34 indexed citations
12.
Sodha, Nayanta, et al.. (2004). Analysis of familial male breast cancer for germline mutations in CHEK2. Cancer Letters. 215(2). 187–189. 11 indexed citations
13.
Sodha, Nayanta, et al.. (2002). A robust method for detectingCHK2/RAD53 mutations in genomic DNA. Human Mutation. 19(2). 173–177. 32 indexed citations
14.
Sodha, Nayanta, Sarah Bullock, Gillian Mitchell, et al.. (2002). CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours. British Journal of Cancer. 87(12). 1445–1448. 52 indexed citations
15.
Kote‐Jarai, Zsofia, S. Ashley, DF Easton, et al.. (2000). BRCA1, BRCA2 and pedigree genetic analysis to determine genetic risk in the UK Royal Marsden Hospital tamoxifen prevention trial. Breast Cancer Research. 2(S1). 1 indexed citations
16.
Sodha, Nayanta, Richard Williams, Jonathan Mangion, et al.. (2000). Screening hCHK2 for Mutations. Science. 289(5478). 359–359. 58 indexed citations
17.
Camplejohn, Richard S., Nayanta Sodha, R Gilchrist, et al.. (2000). The value of rapid functional assays of germline p53 status in LFS and LFL families. British Journal of Cancer. 82(6). 1145–1148. 13 indexed citations
18.
Eeles, Rosalind A., S. Ashley, Douglas F. Easton, et al.. (1999). BRCA1, BRCA2 and pedigree genetic analysis to determine genetic risk in the UK Royal Marsden Hospital tamoxifen prevention trial. The American Journal of Human Genetics. 65(4). 124. 2 indexed citations
19.
Stone, J G, et al.. (1999). Analysis of Li–Fraumeni syndrome and Li–Fraumeni-like families for germline mutations in Bcl10. Cancer Letters. 147(1-2). 181–185. 12 indexed citations
20.
Morrison, A. W., et al.. (1994). On genetic and environmental factors in Menière's disease.. PubMed. 15(1). 35–9. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frank Courjal Breakdown of academic impact, for papers by Tord Jonson Breakdown of academic impact, for papers by Diana Iliev Breakdown of academic impact, for papers by Jonathan Perk Breakdown of academic impact, for papers by Michel Herranz Breakdown of academic impact, for papers by Mary K. Washington Breakdown of academic impact, for papers by Huai-Xiang Hao Breakdown of academic impact, for papers by Sara Volorio Breakdown of academic impact, for papers by Lalitha Nagarajan Breakdown of academic impact, for papers by Sean Young
Rankless by CCL
2026